SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001469709-18-000135
Filing Date
2018-08-14
Accepted
2018-08-14 14:56:57
Documents
40
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 AGGX 10-Q 06/30/18 aggx10q_063018apg.htm 10-Q 272990
2 EXHIBIT 31.1 ex31_1apg.htm EX-31.1 8584
3 EXHIBIT 31.2 ex31_2apg.htm EX-31.2 8653
4 EXHIBIT 32.1 ex32_1apg.htm EX-32.1 3698
5 EXHIBIT 32.2 ex32_2apg.htm EX-32.2 3801
  Complete submission text file 0001469709-18-000135.txt   1121725

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aggx-20180630.xml EX-101.INS 93732
7 XBRL SCHEMA FILE aggx-20180630.xsd EX-101.SCH 25262
8 XBRL CALCULATION FILE aggx-20180630_cal.xml EX-101.CAL 27623
9 XBRL DEFINITION FILE aggx-20180630_def.xml EX-101.DEF 14243
10 XBRL LABEL FILE aggx-20180630_lab.xml EX-101.LAB 123148
11 XBRL PRESENTATION FILE aggx-20180630_pre.xml EX-101.PRE 96456
Mailing Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017
Business Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017 212-874-6608
AngioGenex, Inc. (Filer) CIK: 0001085596 (see all company filings)

IRS No.: 860945116 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26181 | Film No.: 181016591
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1